MVA BN WEV
Alternative Names: Equine encephalitis virus vaccine - Bavarian Nordic; MVA-BN-WEV; MVA-BN-W + E + VLatest Information Update: 11 Apr 2025
At a glance
- Originator Bavarian Nordic
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
Most Recent Events
- 10 Mar 2025 Phase-II clinical trials in Eastern equine encephalomyelitis (Prevention) in USA (IM) (NCT06899802)
- 10 Mar 2025 Phase-II clinical trials in Venezuelan equine encephalomyelitis (Prevention) in USA (IM) (NCT06899802)
- 10 Mar 2025 Phase-II clinical trials in Western equine encephalitis virus infections (Prevention) in USA (IM) (NCT06899802)